Avizakimab (BOS161721) is a humanized IgG1 monoclonal antibody specifically designed to target interleukin-21. This therapeutic protein is engineered to bind selectively to interleukin-21, a cytokine implicated in the pathogenesis of various autoimmune diseases, thereby modulating immune responses and providing potential therapeutic benefits in disorders characterized by excessive or aberrant cytokine activity.
Avizakimab (BOS161721) is a humanized IgG1 monoclonal antibody specifically designed to target interleukin-21. This therapeutic protein is engineered to bind selectively to interleukin-21, a cytokine implicated in the pathogenesis of various autoimmune diseases, thereby modulating immune responses and providing potential therapeutic benefits in disorders characterized by excessive or aberrant cytokine activity.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
